| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |